Ching-Wei Chang
6PUBLICATIONS
93CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 03, 2023
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.Komal L Jhaveri, Meritxell Bellet, Nicholas C Turner
|Jun 01, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo
|Jan 03, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.Charles N Landen, Luciana Molinero, Habib Hamidi
|Sep 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao
|May 18, 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen
|May 13, 2022
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer.Kyung-Min Lee, Chang-Ching Lin, Alberto Servetto
Pageof 1
Frequent Collaborators
3 joint publications
Heather M Moore
2 joint publications
Ciara Metcalfe
2 joint publications
Mary R Gates
2 joint publications
Jose Alejandro Perez Fidalgo
2 joint publications
Aditya Bardia
2 joint publications
Meritxell Bellet
2 joint publications
Jill Fredrickson
2 joint publications
Rafael Villanueva-Vázquez
2 joint publications
Jennifer Giltnane
1 joint publications
Elgene Lim
